Australian Government

Federal Register of Legislation

National Health (Highly Specialised Drugs Program) Special Arrangement 2021

In force

Administered by

Department of Health and Aged Care

This item is authorised by the following title:

National Health Act 1953

Latest version

F2024C00317 (C37)

01 April 2024

Table of contents

Part 1—Preliminary
Part 2—Special arrangement supplies of HSD pharmaceutical benefits
Part 3—Payment for special arrangement supplies of HSD pharmaceutical benefits
- Division 1—Supplies by approved hospital authorities for public hospitals
  - 28 Rates of payment for approved hospital authorities for public hospitals (Act s 99(4))
  - 29 Dispensed price for approved hospital authorities for public hospitals
- Division 2—Supplies by other approved suppliers
Part 4—Claims for payment for special arrangement supplies of HSD pharmaceutical benefits
- 35 Rules for providing information about supplies—definition of under co payment data
Part 5—Miscellaneous
- 36 Compliance and audit arrangements
- 37 Value for safety net purposes for supplies
Part 6—Application, saving and transitional provisions
- Division 1—Provisions relating to this instrument as made
  - 38 HSD hospital authorities
- Division 2—Provisions relating to the National Health Legislation Amendment (Opioid Dependence Treatment and Maximum Dispensed Quantities) Instrument 2023
Schedule 1—HSD pharmaceutical benefits and related information
- 1 Highly specialised drugs and HSD pharmaceutical benefits
Schedule 2—Maximum quantities and repeats for certain HSD pharmaceutical benefits
- 1 Maximum quantity or number of units and maximum number of repeats
Schedule 3—Circumstances and purposes
- 1 Circumstances and purposes
- Endnotes